Cardiovascular Peptides

Product description

The Competitive Intelligence Report Cardiovascular Peptides as of June 2008 provides a competitor analysis in the development pipeline of peptides as novel treatments of heart failure, atherosclerosis, thrombotic indications and acute care. Among the companies active in the field of new cardiovascular peptides are Big Pharma companies Bristol-Myers Squibb and Wyeth, but primarily small biotech companies.

The report includes a compilation of current active projects in research and development of novel antihypertensives.

Competitor projects are listed in a tabular format providing Information on:

• Drug Codes,
• Target / Mechanism of Action,
• Class of Compound,
• Company,
• Product category,
• Indication,
• R&D Stage and
• additional comments with a hyperlink leading to the source of information.